Clinical operations leaders are not prepared for the downstream impact of GPT-Rosalind. Explore the hidden trial infrastructure risks of...
QMENTA Co-Founder Paulo Rodrigues shares observations from LSX World Congress Europe 2026: why biotech's bottleneck is execution, not science, and...
RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
Discover insights into structural and functional aspects of the human brain, potential biomarkers, and applications in psychiatric research.
QMENTA’s hybrid cloud imaging approach combines automated cloud processing with on-premise expert editing for higher accuracy, speed, and...
Compare 6 automated white matter lesion segmentation tools for MS available on QMENTA — including LST-LPA, mediaire Lesion Characterization, SAMSEG,...
Prof. Russ Hornbeck shares insights on Alzheimer's research and imaging technology through his experience in medical imaging, discussing the DIAN...
The 7 trends shaping imaging clinical trials in 2024, including digital twins, decentralized trials, wearables, AI, central reading, psychedelics,...